MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 
Similar Articles
The Motley Fool
January 11, 2005
Lawrence Meyers
Israel at the Forefront Middle East peace could make Israeli stocks more appealing. mark for My Articles similar articles
The Motley Fool
May 26, 2006
Michael Jaffe
What the Oracle Saw in Israel Berkshire Hathaway announced its $4 billion acquisition of 80% of Israel's Iscar Metalworking. While Israelis appreciate this visible financial stamp of approval, there are compelling reasons why the deal should make Berkshire shareholders happy, too. mark for My Articles similar articles
The Motley Fool
November 2, 2010
Eric Dutram
Tuesday's ETF to Watch: iShares Israel ETF (EIS) TEVA reports earnings. mark for My Articles similar articles
BusinessWeek
September 9, 2010
Bhaktavatsalam et al.
Israel Gets an Upgrade, and Investors Depart Now that it's a developed market rather than an emerging one, Harvard, T. Rowe Price, and others are pulling out mark for My Articles similar articles
BusinessWeek
September 26, 2005
Israel Shakes Up Its Banking Sector The Israeli government hopes to get out of the banking business by yearend. mark for My Articles similar articles
National Real Estate Investor
September 1, 2004
Hortense Leon
Israeli Investors Flock to South Florida When Africa-Israel Investments and Brooklyn developer Shaya Boymelgreen announced in July that they were planning to build $1.5 billion of residential and office development near downtown Miami and on South Beach, South Floridians took notice. mark for My Articles similar articles
The Motley Fool
November 8, 2006
Todd Wenning
This Is Not a Fad Unlike disco, international stocks are stayin' alive. mark for My Articles similar articles
The Motley Fool
June 8, 2006
Chuck Saletta
Stocks You Won't Sell If the companies you own pay you well, you may never need to sell them. mark for My Articles similar articles
The Motley Fool
October 31, 2011
Igor Meyerson
Why You Should Always Pay Attention to the Footnotes of a Financial Report When companies make changes in their financial reports they need to make it easier for individuals to spot them. mark for My Articles similar articles
The Motley Fool
February 28, 2006
Stephen D. Simpson
Still Waiting for Teva to Stumble This leading Israeli generics firm hasn't seen a stock pullback of any consequence since mid- to late 2004. And while fourth-quarter results weren't fabulous, they were good enough given the circumstances mark for My Articles similar articles
BusinessWeek
July 2, 2007
Neal Sandler
Israel: A Hotbed Of...Investment Amid tightened security, companies in Israel are thriving at home - and expanding abroad. mark for My Articles similar articles
The Motley Fool
June 28, 2011
Eric Bleeker
Where Is Teva Pharmaceuticals Finding Growth? Teva should see its sales continue to climb, especially in already booming international markets. mark for My Articles similar articles
The Motley Fool
December 15, 2003
Mathew Emmert
Warren, Show Me the Money Why Berkshire Hathaway should pay dividends. mark for My Articles similar articles
The Motley Fool
May 11, 2011
Jared Cummans
Wednesday's ETF to Watch: iShares MSCI Israel Fund Teva Pharmaceuticals releases earnings today. mark for My Articles similar articles
BusinessWeek
May 31, 2004
Lauren Young
One Way To Get New Investors Free mutual fund shares entice people to invest in Israel. mark for My Articles similar articles
The Motley Fool
March 8, 2007
Chuck Saletta
Dueling Fools: Berkshire Hathaway Bear Berkshire Hathaway trades at a premium to other insurers, is stingier to its shareholders than other conglomerates, and looks to be too cash-rich to invest its entire hoard successfully in the future. mark for My Articles similar articles
The Motley Fool
May 5, 2007
Matt Koppenheffer
Quick Take: The Questions Begin Buffett and Munger discuss private equity and overseas investing during the annual Berkshire Hathaway shareholder meeting. mark for My Articles similar articles
Chemistry World
December 2, 2013
Maria Burke
Compromise puts Israel on course to join Europe's science program Israel and the EU have resolved the diplomatic dispute that looked set to shut out Israeli research universities and technology companies from Europe's flagship science program. mark for My Articles similar articles
BusinessWeek
May 2, 2005
Tensions Over Israeli Arms Sales To China Israeli arms deals with China are continuing to make waves in relations between Jerusalem and Washington. mark for My Articles similar articles
Chemistry World
February 11, 2014
Emma Stoye
Dan Shechtman starts presidential campaign Dan Shechtman, who won the chemistry Nobel in 2011 for his work on quasicrystals, has begun his campaign to become president of Israel, meeting with politicians at the Knesset, the legislative arm of Israel's government. mark for My Articles similar articles
The Motley Fool
August 1, 2005
Stephen D. Simpson
Teva: Built to Last? Israeli generics giant Teva Pharmaceuticals is a high-quality company trading at a level that should still provide patient investors with solid long-term performance. mark for My Articles similar articles
The Motley Fool
November 7, 2007
Matt Koppenheffer
Just Another Quarter for Berkshire When it comes to a solid group of businesses like those under the Berkshire umbrella, quarterly reports seem irrelevant. mark for My Articles similar articles
BusinessWeek
December 20, 2004
Tightening Israeli-Egyptian Ties Four free-trade zones will be created in Egypt as a result of a deal to be signed by Israel, Egypt, and the U.S. on Dec. 14. mark for My Articles similar articles
The Motley Fool
April 7, 2010
Rick Steier
Is Teva Pharmaceutical a Forever Hold? Teva is a compelling reason why investors should look abroad for opportunity. mark for My Articles similar articles
The Motley Fool
December 14, 2009
Rich Smith
This Just In: Upgrades and Downgrades Piper Jaffray plays a wrong note on Teva. mark for My Articles similar articles
BusinessWeek
March 7, 2005
A Banner Year For Israeli Arms Exports Israel's budding defense relationship with India continues to expand. mark for My Articles similar articles
BusinessWeek
January 24, 2005
An American Chief For Israel's Central Bank Israel's financial markets welcomed the nomination of Citigroup Vice-Chairman Stanley Fischer as governor of the Bank of Israel, the country's central bank. The Tel Aviv stock index rose 1%, to an all-time high, after the decision was announced. mark for My Articles similar articles
InternetNews
April 22, 2005
IBM Gets Israel in On Demand Start-up ISVs are the target of the latest program to promote on-demand computing systems. mark for My Articles similar articles
The Motley Fool
January 4, 2011
Tony Luckett
Why Buy Berkshire Hathaway? Is Warren Buffett's company worth buying at the moment? mark for My Articles similar articles
Chemistry World
October 14, 2013
Phillip Broadwith
5000 jobs to be cut at Teva Israeli generics heavyweight Teva is accelerating its previously announced costcutting drive. mark for My Articles similar articles
Real Estate Portfolio
Special Issue 2005
Jada A. Graves
Spotlight on the Middle-East Israel may not be the first country that comes to mind when thinking about the global real estate market, but its real estate investment industry is in the early stages of a growth surge. mark for My Articles similar articles
The Motley Fool
July 14, 2010
Jordan DiPietro
Israeli Stocks You Can Actually Buy Finding Israeli stocks on U.S. indices can be difficult, so here's a start. mark for My Articles similar articles
The Motley Fool
July 14, 2010
Alex Dumortier
Berkshire Hathaway Is Extremely Cheap Here's your opportunity to own the ultimate blue chip. mark for My Articles similar articles
Entrepreneur
August 2005
Mark Henricks
Promised Land Working with an Israeli firm may not be as easy as dealing with one across town or even across the United States, but U.S. companies are finding new opportunities by partnering with Israeli firms. mark for My Articles similar articles
BusinessWeek
January 17, 2005
Turkey And Israel Patch It Up Turkey and Israel are trying to mend relations strained by Turkish Prime Minister Recep Tayyip Erdogan's sharp criticism of Israeli actions in the Palestinian territories. mark for My Articles similar articles
The Motley Fool
November 8, 2006
Brian Lawler
Teva Is Rolling in Cash Again Investors, the bottom line is that with 13 proprietary drugs in phase 2 trials or later for some very large indications, plus 144 applications to sell generic versions of branded drugs waiting at the FDA, Teva's near-term future is strong. mark for My Articles similar articles
BusinessWeek
October 7, 2010
Wainer & Ben-David
The Controversy Over Israel's Business Elite With a few business owners controlling a huge part of the economy in Israel, cries for reform are getting louder. mark for My Articles similar articles
The Motley Fool
April 23, 2007
Dave Mock
Foolish Forecast: AT&T's Wireless Ways The telecommunications giant is set to report its first-quarter 2007 earnings results. Investors, here is what you can expect to find. mark for My Articles similar articles
The Motley Fool
June 18, 2010
Morgan Housel
Is Berkshire Hathaway a Buy? Historical valuations are about as low as they've ever been. The elephant acquisition, Burlington Northern, has already been bagged. And there's reason to believe insurance pricing could stage a rebound. mark for My Articles similar articles
The Motley Fool
August 10, 2011
Matt Koppenheffer
Partner Communications Shares Plunged: What You Need to Know Shares of Israeli cell-service provider Partner Communications were getting hung up on by investors today as shares fell as much as 22% in intraday trading on heavier-than-average volume. mark for My Articles similar articles
BusinessWeek
February 23, 2004
Kripalani & Sandler
Building Fences -- And Growing Closer From security to information technology, business ties between India and Israel are proliferating mark for My Articles similar articles
BusinessWeek
November 3, 2003
Diane Brady
Biotech: Teva's Next Triumph? The Israeli maker of generics wants a piece of the fast-growing bio-drug market. mark for My Articles similar articles
The Motley Fool
August 15, 2007
Brian Orelli
Buffett's Drug Deals During the most recent quarter Berkshire Hathaway has increased their holdings in several battered pharmaceutical and medical stocks. mark for My Articles similar articles
The Motley Fool
July 25, 2005
Stephen D. Simpson
Teva Tries to Buy Back the Top Spot $7.4 billion later, Teva Pharmaceuticals is poised to become the largest generics company in the world once again. Investors, take note. mark for My Articles similar articles
The Motley Fool
November 9, 2006
Philip Durell
The Best Blue Chip for 2007: Berkshire Hathaway Management doesn't get any better than Warren Buffett. It's hard to find a better lower-risk investment or a better blue chip than Berkshire Hathaway. mark for My Articles similar articles
The Motley Fool
May 18, 2011
Jordan DiPietro
Should You Buy and Hold Teva Pharmaceutical? The Israeli pharma firm passes all four of our retirement portfolio tests. mark for My Articles similar articles
The Motley Fool
December 7, 2009
Jordan DiPietro
Foreign Stocks You Can Actually Buy: Israel Finding foreign stocks on U.S. indices can be difficult. Here's a start. mark for My Articles similar articles
The Motley Fool
December 6, 2011
Amitabha Chakraborty
Can Noble's Israel Dream Come True? Noble Energy is exploring the idea of building an LNG terminal offshore Israel. mark for My Articles similar articles
The Motley Fool
November 4, 2011
A Brief History of Berkshire Hathaway's Returns The decline in Berkshire's price-to-book value over the past year has been striking. Indeed, valuations fell far enough that Buffett began using Berkshire's cash to repurchase shares in September for the first time ever. mark for My Articles similar articles
Parameters
Spring 2007
Louis Rene Beres
Israel's Uncertain Strategic Future An assessment of current threats to Israel's survival along with recommendations for an end to its policy of nuclear ambiguity. mark for My Articles similar articles